Eli Lilly and Company Will Introduce Generic Insulin at Half Price of Humalog

Eli Lilly and Company today announced it will introduce a lower-priced version of Humalog®(insulin lispro injection 100 units/mL) in the U.S. The …

Novo Nordisk Seeks EMA and FDA Approval for Fiasp® to be Used for Kids

Novo Nordisk recently submitted label updates to the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) for …

Dexcom G6® CGM System Receives Health Canada Approval

Dexcom, Inc. announced last week that the company has received Health Canada approval for its next-generation Dexcom G6 CGM System for people with …

UVA Expanding Telehealth to Better Treat Diabetes, Heart Disease

The University of Virginia Health System is expanding its telehealth capacity to help patients across Virginia better prevent or manage chronic …

Cellular “Sickness” Linked to Type 1 Diabetes Onset

A University California, San Francisco study of human and mouse pancreatic tissue suggests a new origin story for Type 1 diabetes. The findings flip …

Company on Mission to Put 10 Million Type 2 Diabetes Patients into Remission by 2022

Diabetes care is at the forefront of many new innovations, from monitoring devices that synch with apps to devices that track and administer the …

A Conversation with Carl S. Armato and the Story Behind “A Future with Hope”

dLife is proud to bring you an exclusive conversation with prominent executive, Carl S. Armato, in which he shares with us details about his …

Abbott and Novo Nordisk Partner to Provide Digital Solution for Those Using Insulin

Abbott and Novo Nordisk today announced a deal that connects two key technologies: Continuous glucose monitoring (CGM) and connected insulin pens. …

ADA Names Three Awardees for 2019 “Pathway to Stop Diabetes Research” Grants

The American Diabetes Association (ADA) announced recipients of this year’s prestigious Pathway to Stop Diabetes grants, totaling $4.875 million …

Senseonics Partners with Geo-Med to Provide Veterans Access to CGM

Senseonics Holdings, Inc., a company developing long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced …